A stunning wave of public voices has hit Washington. Over 42,000 Americans weighed in on a key federal move to ease cannabis rules. Most now cheer the shift but push hard for full freedom from drug controls.
Researchers dug deep into every comment. They found huge support for change. Yet the crowd wants the government to go further fast.
The Drug Enforcement Administration opened a portal in 2024 for public views. People rushed in during a 63-day window from May 21 to July 22.
This set a new mark with 42,913 comments. It topped all past talks on federal cannabis rules. Folks from patients to business owners shared raw stories.
One line stands out. A whopping 92 percent called to yank cannabis from its strict Schedule I status. That means no more tags of no medical use or high abuse risk.
Experts at Johns Hopkins University and the University of California San Diego led the review. They used smart tech and human checks for solid results.
AI and Humans Reveal Clear Sentiments
The team fed comments into an open-source language model. Humans double-checked a sample of 200 for accuracy. They hit 88 percent agreement.
Findings split clean. Just 6.7 percent opposed any shift. About 29 percent liked the plan for Schedule III.
But 63.5 percent said no, it falls short. They urged total removal or lighter rules.
| Sentiment on Proposal | Percentage |
|---|---|
| Support Schedule III | 28.85% |
| Want more reform | 63.50% |
| Oppose change | 6.74% |
This table shows the split. It proves broad buy-in with a bold call for bold steps.
Top Reasons Drive Support and Pushback
Supporters of the Schedule III idea pointed to real wins. Over half, 56.7 percent, stressed healing power for pain and illness.
Nearly 28 percent eyed cash boosts for states and firms. One in four wanted tight safety rules.
Those crying for more listed fresh angles. Criminal justice reform hit 26.5 percent. They noted unfair jail time in poor areas.
- Therapeutic gains top the list for change fans.
- Economic lifts excite business backers.
- Fairness fixes fire up justice seekers.
Opponents stuck to health fears. Every one warned of risks. Over 70 percent flagged addiction. More than half worried about kids.
New Rules Open Doors for Patients and Science
The Trump team made it real in April 2026. State-approved medical cannabis now sits in Schedule III. This eases taxes and research blocks.
Patients gain easier access to doctor-backed care. Firms dodge harsh 280E tax hits on medical sales. Banks eye safer loans.
Study leaders cheered the start. John Ayers said it matches public hopes but needs speed. Ryan Vandrey pushed for more studies on benefits.
Rescheduling sparks hope for everyday folks battling chronic pain or tough diseases. It nods to state laws in 38 places.
Lives change quick. A vet with PTSD finds relief without stigma. A farmer builds steady income.
Years of state tests shape views. People know cannabis helps. They demand feds catch up.
This shift tests big divides. It blends health needs with old fears. Leaders must hear the roar.
In the end, Americans spoke loud on cannabis rescheduling. Over 90 percent back ditching old bans, with most eyeing full reform. Personal tales of healing, jobs, and justice fuel the fire. It offers real hope amid past wrongs.
Maria Garcia is an award-winning author who excels in creating engaging cannabis-centric articles that captivate audiences. Her versatile writing style allows her to cover a wide range of topics within the cannabis space, from advocacy and social justice to product reviews and lifestyle features. Maria’s dedication to promoting education and awareness about cannabis shines through in her thoughtfully curated content that resonates with both seasoned enthusiasts and newcomers alike.
